Ahmad Awada und Libre De Bruxelles - Info zur Person

(1 - 7 von 10

)

Etirinotecan Pegol Active in Patients With Previously Treated...

ascopost.com

In a phase II study reported in The Lancet Oncology, Ahmad Awada, MD, of Jules Bordet Institute, Université Libre de Bruxelles, and colleagues ...

Ahmad Awada | Faculty Memberfacultyopinions.com › prime › thefaculty › member

facultyopinions.com

Faculty Member: Ahmad Awada. Find peer-reviewed & recommended articles Ahmad Awada. Institut Jules Bordet Universite Libre de Bruxelles Brussels

About - Ahmad Awada - Discovery Medicine

www.discoverymedicine.com

Ahmad Awada, M.D., Ph.D. Specialty: Oncology Institution: Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles

New developments and controversies in breast cancer treatment: PARP...

docplayer.net

Ahmad Awada MD, PhD Medical Oncology Clinic Institut Jules Bordet Université Libre de Bruxelles FOM Lille Her2 breast cancer expression = Poor More information A Phase 1 Study of MM-302, a HER2- targeted PEGylated liposomal doxorubicin, in Patients with HER2-positive Metastatic Breast Cancer (MBC)

Jeanette Borthwick
Ralf Kötter
Khalil Chehadeh

Sanne Buskermolen Holland

Personen
Vorname "Ahmad" (5115)
Name "Awada" (223)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ahmad Awada und Libre De Bruxelles Person-Info

Etirinotecan Pegol Active in Patients With Previously Treated...

Ahmad Awada | Faculty Memberfacultyopinions.com › prime › thefaculty › member

About - Ahmad Awada - Discovery Medicine

New developments and controversies in breast cancer treatment: PARP...

The current treatment landscape for early breast cancer: Advances in...

MedicalResearch.com | Dr-Ahmad-Awada

Molecular biology in medical oncology: diagnosis, prognosis, and ...pubmed.ncbi.nlm.nih.gov › ...

Alle Infos zum Namen "Ahmad Awada"